Adocia | Ownership

Companies that own Adocia

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Talence Gestion SAS
45,000
0.65%
0
0.23%
07/31/2018
Uzes Gestion SA
23,000
0.33%
0
0.3%
08/31/2018
AcomeA SGR SpA
13,190
0.19%
140
0.06%
10/31/2017
Perinvest (UK) Ltd.
13,000
0.19%
13,000
1.57%
06/30/2017
Bruno Walter Finance SA
10,000
0.14%
0
0.2%
02/28/2018
CPR Asset Management SA
6,646
0.1%
5,924
0%
12/30/2016
Monega Kapitalanlagegesellschaft mbH
6,150
0.09%
0
0.02%
07/31/2018
Société Générale Gestion SA
5,516
0.08%
0
0%
01/31/2018
Deka Investment GmbH
5,500
0.08%
5,500
0%
06/29/2018
Fédéral Finance Gestion SA
5,000
0.07%
0
0%
10/31/2016

About Adocia

View Profile
Address
115 avenue Lacassagne
Lyon Rhone-Alpes 69003
France
Employees -
Website http://www.adocia.com
Updated 07/08/2019
Adocia SA is a clinical-stage biotechnology company, which engages in the development of medicines from already-approved therapeutic proteins and peptides. Its product pipelines include: BioChaperone Lispro; BioChaperone Combo; HinsBet; BioChaperone Human Glucagon; BioChaperone Glargine GLP-1; and BioChaperone Prandaial Combinations for T1D. The company was founded by Gérard, Olivier, and Rémi Soula on December 16, 2005 and is headquartered in Lyon, France.